Company Description: Caplin Point Laboratories, established in 1990, has evolved into a leading pharmaceutical company with a diverse product range, specializing in
(CAPLIPOINT)
XNSE:CAPLIPOINT, XBOM:524742
Caplin Point Laboratories Ltd Q4FY23; 25% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd Q1FY24; 21% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT): Q3FY23 Results Out; Total Income rise 15% YoY
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture, and marketing